Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Kaukel · SciRah

Researcher profile · Semantic Scholar

E. Kaukel

Share profile

E. Kaukel — researcher profile on SciRah

h-index: 21
Works: 85
Citations: 6,498

Most-cited papers

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
N. Vogelzang, J. Rusthoven, J. Symanowski, C. Denham +8 more
2003Journal of Clinical Oncology2,970 citations
Semantic Scholar
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
F. Fossella, J. R. Pereira, J. von Pawel, A. Płużańska +8 more
2003Journal of Clinical Oncology958 citations
Semantic Scholar
Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.
U. Gatzemeier, A. Płużańska, A. Szczesna, E. Kaukel +12 more
2007Journal of Clinical Oncology837 citations
Semantic Scholar
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)
U. Gatzemeier, A. Płużańska, A. Szczesna, E. Kaukel +5 more
2004267 citations
Semantic Scholar
Phase III trial comparing paclitaxel poliglumex vs docetaxel in the second-line treatment of non-small-cell lung cancer
L. Paz-Ares, H. Ross, M. O'Brien, A. Rivière +16 more
2008British Journal of Cancer162 citations Open access
Semantic Scholar
SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: phase III results.
M. O'Brien, H. Anderson, E. Kaukel, K. O'Byrne +3 more
2004Annals of Oncology134 citations Open access
Semantic Scholar
Permeation of dibutyryl cAMP into HeLa cells and its convesion to monobutyryl cAMP.
E. Kaukel, Helmuth Hilz
1972Biochemical and Biophysical Research Communications - BBRC128 citations
Semantic Scholar
Phase III study comparing oral topotecan to intravenous docetaxel in patients with pretreated advanced non-small-cell lung cancer.
R. Ramlau, R. Gervais, M. Krzakowski, J. von Pawel +7 more
2006Journal of Clinical Oncology115 citations
Semantic Scholar
Total Pulmonary Vein Occlusion as a Consequence of Catheter Ablation for Atrial Fibrillation Mimicking Primary Lung Disease
S. Ernst, F. Ouyang, M. Goya, Felix Löber +9 more
2003Cardiovascular Electrophysiology106 citations
Semantic Scholar
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC).
U. Gatzemeier, A. Płużańska, A. Szczesna, E. Kaukel +5 more
2004Journal of Clinical Oncology91 citations
Semantic Scholar
Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer.
M. Reck, J. von Pawel, H. Macha, E. Kaukel +5 more
2003Journal of the National Cancer Institute88 citations
Semantic Scholar
N6‐Monobutyryladenosine 3′ : 5′‐Monophosphate as the Biologically Active Derivative of Dibutyryladenosine 3′ : 5′‐Monophosphate in HeLa S3 Cells
E. Kaukel, K. Mundhenk, H. Hilz
197268 citations
Semantic Scholar
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
C. Belani, J. R. Pereira, J. von Pawel, A. Płużańska +8 more
2006Lung Cancer62 citations
Semantic Scholar
Phase II trial of ZD0473 as second-line therapy in mesothelioma.
G. Giaccone, M. O'Brien, M. Byrne, M. Bard +2 more
2002European Journal of Cancer55 citations
Semantic Scholar
Divergent action of cAMP and dibutyryl cAMP on macromolecular synthesis in HeLa S3 cultures.
E. Kaukel, U. Fuhrmann, Helmuth Hilz
1972Biochemical and Biophysical Research Communications - BBRC48 citations
Semantic Scholar
Single-Agent Pemetrexed or Sequential Pemetrexed/Gemcitabine as Front-Line Treatment of Advanced Non-small Cell Lung Cancer in Elderly Patients or Patients Ineligible for Platinum-Based Chemotherapy: A Multicenter, Randomized, Phase II Trial
C. Gridelli, E. Kaukel, V. Gregorc, M. Migliorino +11 more
2007Journal of Thoracic Oncology46 citations Open access
Semantic Scholar
Lenograstim as support for ACE chemotherapy of small-cell lung cancer: a phase III, multicenter, randomized study.
U. Gatzemeier, J. Kleisbauer, P. Drings, E. Kaukel +7 more
2000American Journal of Clinical Oncology43 citations
Semantic Scholar
A phase II study of pirarubicin in malignant pleural mesothelioma
E. Kaukel, G. Koschel, U. Gatzemeyer, E. Salewski
1990Cancer34 citations
Semantic Scholar
Phase III trial with and without lonidamine in non-small cell lung cancer.
U. Gatzemeier, F. Cavalli, K. Häussinger, E. Kaukel +4 more
1991Seminars in Oncology30 citations
Semantic Scholar
Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
A. Bakhshandeh, I. Bruns, A. Traynor, H. Robins +13 more
2003Lung Cancer29 citations
Semantic Scholar
Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
M. Reck, J. von Pawel, H. Macha, E. Kaukel +5 more
2006Lung Cancer26 citations
Semantic Scholar
[Chemotherapy of advanced non-small-cell and small-cell bronchial carcinoma with bendamustine--a phase II study].
M. Reck, B. Haering, G. Koschel, E. Kaukel +2 more
1998Pneumologie21 citations
Semantic Scholar
A Randomized Trial with Mitomycin‐C/Ifosfamide Versus Mitomycin‐C/Vindesine Versus Cisplatin/Etoposide in Advanced Non‐Small-Cell Lung Cancer
U. Gatzemeier, M. Heckmayr, D. Hossfeld, E. Kaukel +2 more
1991American Journal of Clinical Oncology16 citations
Semantic Scholar
A phase III trial of taxol, etoposide phosphate and carboplatin (TEC) versus carboplatin, etoposide phosphate and vincristine (CEV) in previously untreated small cell lung cancer (SCLC)
U. Gatzemeier, B. Faderl, H. Macha, E. Kaukel +3 more
200014 citations
Semantic Scholar
Oral topotecan demonstrates clinical activity in relapsed non-small cell lung cancer. Results from an open-label, phase III study (387) comparing oral topotecan to intravenous docetaxel
R. Ramlau, R. Gervais, M. Krzakowski, J. von Pawel +6 more
200513 citations
Semantic Scholar
O-56 Symptom and quality of life advantages for pemetrexed + cisplatin versus cisplatin in treatment of malignant pleural mesothelioma
M. Boyer, J. Jassem, A. Liepa, J. Symanowski +6 more
200313 citations
Semantic Scholar
Paclitaxel, carboplatin, and oral etoposide: a phase II trial in limited-stage small cell lung cancer.
U. Gatzemeier, U. Jagos, E. Kaukel, G. Koschel +1 more
1997Seminars in Oncology12 citations
Semantic Scholar
Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases
J. Mezger, A. Calavrezos, P. Drings, U. Gatzemeier +6 more
2004Lung11 citations
Semantic Scholar
Long-term survival in SCLC after treatment with paclitaxel, carboplatin and etoposide--a phase II study.
M. Reck, U. Jagos, F. Grunwald, E. Kaukel +4 more
2003Lung Cancer11 citations
Semantic Scholar
P-452 Phase III study of docetaxel-cisplatin (DC) or docetaxel-carboplatin (DCb) versus vinorelbine-cisplatin (VC) as first-line treatment of advanced non-small cell lung cancer (NSCLC): Analyses by gender
C. Belani, J. von Pawel, Anna Pluzanska, V. Gorbounova +6 more
200510 citations
Semantic Scholar
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
N. Vogelzang, J. Rusthoven, J. Symanowski, C. Denham +8 more
2023Journal of Clinical Oncology9 citations
Semantic Scholar
CAMP dependent and cAMP independent alterations of lung hemodynamic in the pig.
E. Kaukel, S. Siemssen, N. Völkel, V. Sill
1975Biochemical Pharmacology8 citations
Semantic Scholar
Divergent action mechanism of cAMP and dibutyryl cAMP on cell proliferation and macromolecular synthesis in HeLa S3 cultures
H. Hilz, E. Kaukel
1973Molecular and Cellular Biochemistry8 citations
Semantic Scholar
Basal cAMP in Hela cells is protected from phosphodiesterase and does not turn over.
Helmuth Hilz, E. Kaukel, U. Wiegers, U. Fuhrmann
1975Biochemical and Biophysical Research Communications - BBRC7 citations
Semantic Scholar
N 6 -monobutyryladenosine 3':5'-mono phosphate as the biologically active derivative of dibutyryladenosine 3':5'-monophosphate in HeLa S3 cells.
E. Kaukel, K. Mundhenk, H. Hilz
1972European Journal of Biochemistry7 citations
Semantic Scholar
Multiple pulmonary (hamartomatous?) leiomyomas
A. Burkhardt, Herwart F. Otto, E. Kaukel
1981Virchows Archiv6 citations
Semantic Scholar
The significance of cyclic 3′5′-AMP for the euler-liljestrand mechanism
V. Sill, E. Kaukel, N. Völkel, S. Siemssen
2005Beiträge zur Klinik und Erforschung der Tuberkulose und der Lungenkrankheiten5 citations
Semantic Scholar
Effects of hypoxia on pulmonary vascular reactions and on lung cGMP and cAMP in pigs.
E. Kaukel, N. Völkel, Karlgeorg Lanser, Volker Sill
1978Biochemical Pharmacology5 citations
Semantic Scholar
Accumulation of histamine and cyclic nucleotides in lung tissue during chronic hypobaric hypoxia
N. Völkel, E. Kaukel, J. Trautmann
1978Lung4 citations
Semantic Scholar
O-109 Improved quality of life with the addition of SRL172 (killed mycobacterium vaccae) to standard chemotherapy in patients with advanced non-small cell lung cancer: Phase III results
M. O'Brien, H. Anderson, E. Kaukel, K. O'Byrne +3 more
20033 citations
Semantic Scholar
111 Chemotherapy of limited stage small cell lung cancer with carboplatin, paclitaxel and oral etoposide-A phase II-trial
M. Reck, U. Jagos, E. Kaukel, G. Koschel +4 more
19973 citations
Semantic Scholar
[Therapy of malignant pleural mesothelioma].
E. Kaukel, G. Koschel
1991Medizinische Klinik3 citations
Semantic Scholar
Partial beta-adrenergic receptor blockade in experimental bronchial asthma.
E. Kaukel, Barbara Rieckenberg
1980Biochemical and Biophysical Research Communications - BBRC3 citations
Semantic Scholar
The Importance of the ß- Receptor System for the von Euler-Liljestrand Mechanism
S. Siemssen, N. Völkel, V. Sill, E. Kaukel
19753 citations
Semantic Scholar
Histamine-an important mediator for the Euler-Liljestrand mechanism?
N. Völkel, W. Duschek, E. Kaukel, W. Beier +2 more
1975Beiträge zur Klinik und Erforschung der Tuberkulose und der Lungenkrankheiten2 citations
Semantic Scholar
[Hemoperfusion--a therapeutic alternative to early treatment of acute lindane poisoning].
W. Daerr, E. Kaukel, A. Schmoldt
2008Deutsche Medizinische Wochenschrift1 citations
Semantic Scholar
[Conservative, palliative therapy of malignant pleural mesothelioma].
E. Kaukel, G. Koschel, P. Schulz
1992Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress1 citations
Semantic Scholar
[Pulmonary circulation in pulmonary fibrosis].
E. Kaukel
1988Der Internist1 citations
Semantic Scholar
The Influence of Nifedipine, a Calcium Channel Blocker, on Allergen-Induced Bronchoconstriction
G. Koppermann, E. Kaukel
19851 citations
Semantic Scholar
[Posture-dependent changes in lung function and cardiovascular parameters in pregnant females at delivery date].
F. Schneider-Affeld, E. Kaukel, K. Nienstedt
1983Zeitschrift fur Geburtshilfe und Perinatologie1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. von Pawel×19
Invite
J. von Pawel — researcher profile on SciRah
U. Gatzemeier×18
Invite
U. Gatzemeier — researcher profile on SciRah
G. Koschel×11
Invite
G. Koschel — researcher profile on SciRah
M. Reck×7
Invite
M. Reck — researcher profile on SciRah

×6

Invite

R. Ramlau — researcher profile on SciRah

Invite

N. Völkel — researcher profile on SciRah

A. Płużańska×5

Invite

A. Płużańska — researcher profile on SciRah

Invite

A. Szczesna — researcher profile on SciRah

Invite

S. Hessler — researcher profile on SciRah

Invite

S. Siemssen — researcher profile on SciRah

Invite

V. Sill — researcher profile on SciRah

J. Symanowski×3

Invite

J. Symanowski — researcher profile on SciRah